MedPath

Treatment for public speaking fears

Phase 4
Conditions
Public speaking anxiety
Mental Health - Anxiety
Registration Number
ACTRN12610000587000
Lead Sponsor
Macquarie University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
140
Inclusion Criteria

To be eligible for participation in the study, individuals will be required to score 16 or above on the Personal Report of Confidence as a Speaker (PRCS) and 80 or above on the Personal Report of Communication Apprehension (PRCA). Participants will be given written information outlining the study and written consent will be required before individuals can participate

Exclusion Criteria

Consistent with previous research the exclusion criteria for participation in the study will be a diagnosis of major depression, bipolar disorder, psychotic symptoms, kidney disease, epilepsy, pregnancy or intention to become pregnant, substance dependence and participation in other psychological treatments. Participants will be advised to cease caffeine, nicotine and alcohol consumption on the days they are attending treatment sessions

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reductions in anxiety as measured by the Depression Anxiety Stress Scale (DASS-21), Shortened version of the Social Phobia Scale (SPS), Social Interaction Anxiety Scale (SIAS), and Personal Report of Communication Apprehension (PRCA-24)[Prior to the commencement of treatment, and after treatment has been completed (treatment = 5 weeks duration)]
Secondary Outcome Measures
NameTimeMethod
Improvement in public speaking competency as measured by the Personal Report of Confidence as a Speaker (PRCS)[Prior to the commencement of treatment, and after treatment has been completed (treatment = 5 weeks duration)]
© Copyright 2025. All Rights Reserved by MedPath